ABBV
AbbVie Inc.
Key Financials
Net Income
$4.2B
↑ 132.7%
Gross Profit
$12.1B
↑ 12.7%
Revenue
$61.2B
↑ 268.0%
Operating Income
$15.1B
↑ 65.0%
Total Assets
$134.0B
↓ 0.9%
EPS (Diluted)
$2.36
↑ 131.4%
Shareholders' Equity
$-3270000000.00
↓ 198.3%
Long-term Debt
$64.5B
↓ 3.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABBV |
| Company Name | AbbVie Inc. |
| CIK | 1551152 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (847) 932-7900 |